Tenelia M SR Tab. 10/750mg

Ingredient

Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride

Content

Teneligliptin Hydrobromide Hydrate 15.5mg (10mg as Teneligliptin), Metformin Hydrochloride 750mg

Indication

This drug is administered as an adjunct to diet and exercise to adult patients with type 2 diabetes whom combined therapy of teneligliptin and metformin is appropriate.

– Patients who sufficient glucose control cannot be achieved with metformin monotherapy
– Replacing teneriglitin and metformin combined therapy
– sulfonylureas and this drug can be administered in combined therapy when sufficient glucose control cannot be achieved with metformin and sulfonylurea combined therapy.